Drugmakers Merck and Novartis recently updated their 340B contract pharmacy restrictions, modifying what states are exempt from such policies following [...] …
Category: Contract Pharmacy Protection Bills
A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...] …
Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...] …
As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...] …
A Washington D.C. dark money group with White House ties recently upped its attacks on 340B contract pharmacy access bills [...] …
News Alert
Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference
Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...] …
340B contract pharmacy access bills could cost states millions and employer health plans more, according to a new study funded [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Conservative groups and advocates have recently ramped up efforts to combat the growing number of state 340B contract pharmacy access [...] …
Ireland-based Alkermes announced this week that it will become the third drugmaker to reinstate contract pharmacy restrictions in Kansas and [...] …